MOLECULAR CHARACTERIZATION OF MUSCARINIC ACH RECEPTORS

毒蕈碱 ACH 受体的分子表征

基本信息

  • 批准号:
    3402166
  • 负责人:
  • 金额:
    $ 8.27万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1985
  • 资助国家:
    美国
  • 起止时间:
    1985-09-23 至 1988-08-31
  • 项目状态:
    已结题

项目摘要

The long-range goal of this work is to understand how signal transduction is established and maintained at CNS cholinergic synapses; its focus is on the biochemistry, development and cellular regulation of muscarinic ACh receptors. These receptors mediate a large proportion of CNS cholinergic signaling, have been implicated in many behaviorally and clinically significant phenomena and show a broad spectrum of transductional and regulatory responses. At present, it appears most appropriate to isolate and begin characterizing receptor system proteins and to generate receptor specific antibodies for studies of muscarinic cell and developmental biology. The following three aims have therefore been chosen: AIM #1--To generate a library of muscarinic receptor-specific monoclonal antibodies. Partially purified (250-fold) bovine brain receptors will be used for antibody induction using a combination of methods already tested for their effectiveness. Binding assays and western blots will be used in testing antibody specificity. AIM #2--To purify and begin characterization of receptor molecules. Immunoaffinity chromatography will be added to tested separations based on subcellular fractionation, hydrophobicity, charge, molecular weight and specific glycosylation. 2D-Gel, sedimentation equilibrium and N-terminal analyses will be used in testing purity. The ligand specificity, number of subunits, number of binding sites, and overall amino acid composition of the purified molecules will be assessed. AIM #3--To localize receptors as a function of synaptic development, post-translational modification, and cholinergic stimulation. The monoclonal antibodies obtained above will be used to localize receptors on avian retina neurons at the subcellular and ultrastructural levels. A novel approach employing isolation of differentiated neurons and HVEM whole mount analysis will be used.
这项工作的长期目标是了解信号转导如何

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

WILLIAM L KLEIN其他文献

WILLIAM L KLEIN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('WILLIAM L KLEIN', 18)}}的其他基金

Physiological role of naturally-occuring amyloid beta oligomers
天然存在的β淀粉样蛋白寡聚体的生理作用
  • 批准号:
    9759747
  • 财政年份:
    2018
  • 资助金额:
    $ 8.27万
  • 项目类别:
Development of a non-fibrillic amyloid-beta oligomer selective positron emission tomography imaging diagnostic for Alzheimer.
开发用于阿尔茨海默氏症的非纤维状淀粉样蛋白-β寡聚物选择性正电子发射断层扫描成像诊断。
  • 批准号:
    9202960
  • 财政年份:
    2016
  • 资助金额:
    $ 8.27万
  • 项目类别:
A novel, nanoparticle-based molecular MRI probe for early Alzheimer's diagnostics
一种用于早期阿尔茨海默病诊断的新型纳米粒子分子 MRI 探针
  • 批准号:
    8842908
  • 财政年份:
    2014
  • 资助金额:
    $ 8.27万
  • 项目类别:
A novel, nanoparticle-based molecular MRI probe for early Alzheimer's diagnostics
一种用于早期阿尔茨海默病诊断的新型纳米粒子分子 MRI 探针
  • 批准号:
    8683797
  • 财政年份:
    2014
  • 资助金额:
    $ 8.27万
  • 项目类别:
Alzheimer's Drug Discovery Using Unique Nanotechnology Platform
使用独特的纳米技术平台发现阿尔茨海默病药物
  • 批准号:
    8548221
  • 财政年份:
    2012
  • 资助金额:
    $ 8.27万
  • 项目类别:
Alzheimer's Drug Discovery Using Unique Nanotechnology Platform
使用独特的纳米技术平台发现阿尔茨海默病药物
  • 批准号:
    8446087
  • 财政年份:
    2012
  • 资助金额:
    $ 8.27万
  • 项目类别:
ADDLs, synapses & the molecular etiology of Alzheimer's disease
ADDL、突触
  • 批准号:
    7615522
  • 财政年份:
    2007
  • 资助金额:
    $ 8.27万
  • 项目类别:
ADDLs, synapses & the molecular etiology of Alzheimer's disease
ADDL、突触
  • 批准号:
    7184209
  • 财政年份:
    2007
  • 资助金额:
    $ 8.27万
  • 项目类别:
ADDLs, synapses & the molecular etiology of Alzheimer's disease
ADDL、突触
  • 批准号:
    7470605
  • 财政年份:
    2007
  • 资助金额:
    $ 8.27万
  • 项目类别:
Abeta oligomers (ADDLs) in Alzheimers Disease pathology
阿尔茨海默病病理学中的 Abeta 寡聚物 (ADDL)
  • 批准号:
    6678227
  • 财政年份:
    2003
  • 资助金额:
    $ 8.27万
  • 项目类别:

相似海外基金

Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
  • 批准号:
    10506915
  • 财政年份:
    2021
  • 资助金额:
    $ 8.27万
  • 项目类别:
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
  • 批准号:
    10325006
  • 财政年份:
    2021
  • 资助金额:
    $ 8.27万
  • 项目类别:
SBIR Phase I: A New Class of Immobilized Metal Affinity Chromatography Resins
SBIR 第一阶段:一类新型固定金属亲和色谱树脂
  • 批准号:
    1746198
  • 财政年份:
    2018
  • 资助金额:
    $ 8.27万
  • 项目类别:
    Standard Grant
Marine speciation of nickel using immobilized nickel affinity chromatography
使用固定镍亲和色谱法测定镍的海洋形态
  • 批准号:
    512537-2017
  • 财政年份:
    2017
  • 资助金额:
    $ 8.27万
  • 项目类别:
    University Undergraduate Student Research Awards
I-Corps: Commercialization of Immobilized Metal Affinity Chromatography Resins Based on Nanomaterials
I-Corps:基于纳米材料的固定化金属亲和层析树脂的商业化
  • 批准号:
    1404605
  • 财政年份:
    2014
  • 资助金额:
    $ 8.27万
  • 项目类别:
    Standard Grant
Antibody Purification via Affinity Chromatography that Utilizes the Unconventional Nucleotide Binding Site
利用非常规核苷酸结合位点通过亲和色谱法纯化抗体
  • 批准号:
    1263713
  • 财政年份:
    2013
  • 资助金额:
    $ 8.27万
  • 项目类别:
    Continuing Grant
Development of multivalent DNA network based affinity chromatography diagnostics for isolating circulating tumour cells
开发基于多价 DNA 网络的亲和色谱诊断法,用于分离循环肿瘤细胞
  • 批准号:
    425749-2012
  • 财政年份:
    2012
  • 资助金额:
    $ 8.27万
  • 项目类别:
    Postgraduate Scholarships - Master's
Next-Generation Affinity Chromatography with PEGylated Ligands
使用聚乙二醇化配体的新一代亲和色谱法
  • 批准号:
    1159886
  • 财政年份:
    2012
  • 资助金额:
    $ 8.27万
  • 项目类别:
    Standard Grant
Immobilized zirconium ion affinity chromatography for specific enrichment of phosphoproteins
用于磷蛋白特异性富集的固定化锆离子亲和层析
  • 批准号:
    19560760
  • 财政年份:
    2007
  • 资助金额:
    $ 8.27万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Accelerating drug discovery using frontal affinity chromatography/mass spectrometry
使用正面亲和色谱/质谱加速药物发现
  • 批准号:
    234753-2000
  • 财政年份:
    2003
  • 资助金额:
    $ 8.27万
  • 项目类别:
    Collaborative Research and Development Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了